- Corporate Officers - A
- Ahmed Nadim
Insider Trading History of Ahmed Nadim
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ahmed Nadim since 2018.
This trader's CIK number is 1731193.
At the time of last reporting, Ahmed Nadim was the President and CEO of Cullinan Oncology, Inc.. (stock ticker symbol CGEM).
Also see all insider trading activities at Cullinan Oncology, Inc..
Note that in the past
AHMED NADIM also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cullinan Oncology, Inc. (CGEM) by Ahmed Nadim
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | CGEM | 0 | $0 | 7,160 | $69,596 | 0 | $0 |
| 2022 | CGEM | 8,090 | $100,316 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Celgene Corp /de/ (CELG) by Ahmed Nadim
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | CELG | 0 | $0 | 0 | $0 | 1,563 | $0 |
| 2018 | CELG | 0 | $0 | 0 | $0 | 3,000 | $0 |
Yearly summary of insider trading at Bristol Myers Squibb Co (BMY) by Ahmed Nadim
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | BMY | 0 | $0 | 0 | $0 | 14,946 | $0 |
| 2020 | BMY | 0 | $0 | 0 | $0 | 33,432 | $0 |
Insider trading activities at 3 companies by Ahmed Nadim:
1. Cullinan Oncology, Inc. (CGEM)
2. Celgene Corp /de/ (CELG)
3. Bristol Myers Squibb Co (BMY)
Table 1. Insider trading of Cullinan Oncology, Inc. (CGEM) by Ahmed Nadim
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-12-26 | CGEM | Sale | 4,272 | 9.24 | 39,473 |
| 2023-06-28 | CGEM | Sale | 759 | 11.40 | 8,652 |
| 2023-05-23 | CGEM | Sale | 707 | 9.15 | 6,469 |
| 2023-04-25 | CGEM | Sale | 716 | 10.59 | 7,582 |
| 2023-03-23 | CGEM | Sale | 706 | 10.51 | 7,420 |
| 2022-06-06 | CGEM | Buy | 8,090 | 12.40 | 100,316 |
Table 2. Insider trading of Celgene Corp /de/ (CELG) by Ahmed Nadim
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-05-02 | CELG | Option Ex | 1,563 | .00 | 0 |
| 2018-12-16 | CELG | Option Ex | 3,000 | .00 | 0 |
Table 3. Insider trading of Bristol Myers Squibb Co (BMY) by Ahmed Nadim
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-12-31 | BMY | Option Ex | 14,946 | .00 | 0 |
| 2020-12-02 | BMY | Option Ex | 6,594 | .00 | 0 |
| 2020-10-30 | BMY | Option Ex | 4,650 | .00 | 0 |
| 2020-05-01 | BMY | Option Ex | 2,908 | .00 | 0 |
| 2020-03-01 | BMY | Option Ex | 17,204 | .00 | 0 |
| 2020-02-04 | BMY | Option Ex | 2,076 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Ahmed Nadim
(President and CEO of Cullinan Oncology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.